Compare FICO & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FICO | GEHC |
|---|---|---|
| Founded | 1956 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2B | 33.1B |
| IPO Year | 1987 | N/A |
| Metric | FICO | GEHC |
|---|---|---|
| Price | $1,809.31 | $83.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $2,050.69 | $86.67 |
| AVG Volume (30 Days) | 171.1K | ★ 4.2M |
| Earning Date | 02-03-2026 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | 29.78 | ★ 32.35 |
| EPS | ★ 26.54 | 4.83 |
| Revenue | $1,990,869,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $24.77 | $6.33 |
| Revenue Next Year | $17.55 | $4.38 |
| P/E Ratio | $69.52 | ★ $17.38 |
| Revenue Growth | ★ 15.91 | 3.51 |
| 52 Week Low | $1,300.00 | $57.65 |
| 52 Week High | $2,217.60 | $94.80 |
| Indicator | FICO | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 57.39 | 61.25 |
| Support Level | $1,724.43 | $83.56 |
| Resistance Level | $1,858.91 | $86.19 |
| Average True Range (ATR) | 46.74 | 2.22 |
| MACD | 0.47 | 0.32 |
| Stochastic Oscillator | 65.60 | 71.87 |
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).